Research has indicated that polymorphisms in the ATG16L1 gene are associated with an elevated risk of developing plaque psoriasis, and that ATG16L1 expression is augmented in the dendritic cells of patients with psoriatic arthritis [67,68]. The gene discussed is ATG16L1; the disease is psoriasis vulgaris.